Aarey Drugs & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.

Results View source PDF Explain this filing

AAREYDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.9%Reaction day

₹96.90

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-0.8% vs market

On the reaction day the stock moved 0.8 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-0.9-0.1-0.8

Next day

+0.1+0.5-0.4

-1.9-0.3-1.6

-0.4-0.5+0.1

-2.4-0.8-1.6

-4.4-2.3-2.1

-5.7-2.8-2.9

15d

-22.7-4.9-17.9

-33.7-4.7-28.9

-34.0-7.7-26.3

-33.2-7.8-25.4

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Aarey Drugs & Pharmaceuticals Limited has submitted its financial results for the half-year period ending September 30, 2025 to the stock exchange. The announcement confirms only the filing of results, with no specific revenue, profit, or margin figures disclosed in this notice. No auditor's qualification, restatement note, or exceptional item has been highlighted in this filing.

Likely market impact

Investors should wait for the detailed financial results to assess revenue growth, profitability, and any auditor observations, as this notice is merely a compliance disclosure of submission.